Flow-cytometric studies with eleutherococcus senticosus extract as an immunomodulatory agent.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/2963645
Conclusion of this study
The most salient feature in the verum group was a drastic increase in the absolute number of immunocompetent cells, with an especially pronounced effect on T lymphocytes, predominantly of the helper/inducer type, but also on cytotoxic and natural killer cells. In addition, a general enhancement of the activation state of T lymphocytes was observed. No side effects were observed during the trial or afterwards (observation period 6 months).
Supplements analyzed in this study
|
Health conditions analyzed in this study
No health conditions information for this study.Functions related to this study
|
||
|
Body systems related to this study
Immune System |